cpccoet Search Results


94
Tocris cpccoet
Figure 3. Effects <t>of</t> <t>3,5-DHPG</t> on [3H]D-ASP and [3H]GABA-evoked exocytosis from human neocortical synaptosomes: antagonism by <t>CPCCOEt</t> or MPEP and western blot analysis of mGlu1/5 receptor proteins. (A) Kþ (12 mM)-evoked release of [3H]D-ASP. (B) Kþ (12 mM)-evoked release of [3H]GABA. Results are expressed as induced overflow. Time course relationship of the 12 mM Kþ-evoked release of [3H]D-ASP (C) and [3H]GABA (D) in the absence (gray circles) and in the presence (black circles) of 50 lM 3,5DHPG. Results are expressed as % of total tritium content. When not shown, error bars are within graph symbols. Data are means ± standard error of the mean of 4 (A, C) and 3 (B, D) experiments run in triplicate. *P \ 0.05 at least versus 12 mM Kþ; §P \ 0.05 at least versus 12 mM Kþ/1 lM MPEP; #P \ 0.05 at least versus respective 12 mM Kþ-evoked neurotransmitter release (expressed as % of total tritium content). (E) Western blot analysis of mGlu1 and mGlu5 receptor proteins in DS-Syn fractions isolated from human neocortical synaptosomes. The figure represents a western blot comparing the mGlu1 and mGlu5 receptor immunor- eactivities in a fraction enriched in human neocortical synaptosomal membranes. Anti-Stx-1A was used as a selective neuronal marker; 25-lg protein/lane were applied to the SDS-PAGE gel. Protein weights are in kDa. The blot in the figure is representative of 4 blots from synaptosomal preparations obtained from different patients, in different days.
Cpccoet, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/pm20034999-119-29-33?v=Tocris
Average 94 stars, based on 1 article reviews
cpccoet - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
GraphPad Software Inc cpccoet
Differential changes <t>of</t> <t>mGluR1-</t> and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas <t>CPCCOEt</t> (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.
Cpccoet, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/pmc06742141-439-43-83?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
cpccoet - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Biomol GmbH 7-(hydroxy- imino)cyclopropan-[b]chromen-1a-carboxylic acid ethylester (cpccoet)
Differential changes <t>of</t> <t>mGluR1-</t> and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas <t>CPCCOEt</t> (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.
7 (Hydroxy Imino)cyclopropan [B]Chromen 1a Carboxylic Acid Ethylester (Cpccoet), supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/pm17877638-45-0-12?v=Biomol+GmbH
Average 90 stars, based on 1 article reviews
7-(hydroxy- imino)cyclopropan-[b]chromen-1a-carboxylic acid ethylester (cpccoet) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Microm International GmbH cpccoet
Differential changes <t>of</t> <t>mGluR1-</t> and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas <t>CPCCOEt</t> (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.
Cpccoet, supplied by Microm International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/10__1016_slash_j__npep__2009__08__001-855-21-24?v=Microm+International+GmbH
Average 90 stars, based on 1 article reviews
cpccoet - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Biomol GmbH 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester (cpccoet)
Differential changes <t>of</t> <t>mGluR1-</t> and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas <t>CPCCOEt</t> (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.
7 Hydroxyiminocyclopropan[B]Chromen 1a Carboxylic Acid Ethyl Ester (Cpccoet), supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/pm21134719-73-1-13?v=Biomol+GmbH
Average 90 stars, based on 1 article reviews
7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester (cpccoet) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies cpccoet
Differential changes <t>of</t> <t>mGluR1-</t> and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas <t>CPCCOEt</t> (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.
Cpccoet, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/pm15845088-87-13-3?v=Federation+of+European+Neuroscience+Societies
Average 90 stars, based on 1 article reviews
cpccoet - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Novartis cpccoet
Figure 8. mGluR5 mediates group I mGluR-induced potentiation of NMDA-evoked currents. A, Current traces of NMDA-evoked currents before, during, and after application of DHPG (100 mM). The potentiation is blocked <t>by</t> <t>MPEP</t> (10 mM) but not <t>CPCCOEt</t> (100 mM). B, Mean data 6 SEM of percent potentiation of NMDA-evoked currents by DHPG over predrug conditions. MPEP (10 mM) significantly blocks potentiation of NMDA-evoked current compared with DHPG alone (*p , 0.05).
Cpccoet, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpccoet/10__1523_slash_jneurosci__20___21___07871__2000-41-33-28?v=Novartis
Average 86 stars, based on 1 article reviews
cpccoet - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

N/A
CPCCOEt (#C-370) is a highly pure, synthetic, and biologically active compound.
  Buy from Supplier


N/A
CPCCOEt is a reversible and non-competitive antagonist of mGluR-1 (type 1a mGluR-1 ametabotropic glutamate receptor) activation. Inhibition of the mGluR-1(mGluR-1metabotropic glutamate receptor 1) signal does not affect glutamate binding (IC50=6.5 μM). Studies propose that CPCCOEt
  Buy from Supplier


Image Search Results


Figure 3. Effects of 3,5-DHPG on [3H]D-ASP and [3H]GABA-evoked exocytosis from human neocortical synaptosomes: antagonism by CPCCOEt or MPEP and western blot analysis of mGlu1/5 receptor proteins. (A) Kþ (12 mM)-evoked release of [3H]D-ASP. (B) Kþ (12 mM)-evoked release of [3H]GABA. Results are expressed as induced overflow. Time course relationship of the 12 mM Kþ-evoked release of [3H]D-ASP (C) and [3H]GABA (D) in the absence (gray circles) and in the presence (black circles) of 50 lM 3,5DHPG. Results are expressed as % of total tritium content. When not shown, error bars are within graph symbols. Data are means ± standard error of the mean of 4 (A, C) and 3 (B, D) experiments run in triplicate. *P \ 0.05 at least versus 12 mM Kþ; §P \ 0.05 at least versus 12 mM Kþ/1 lM MPEP; #P \ 0.05 at least versus respective 12 mM Kþ-evoked neurotransmitter release (expressed as % of total tritium content). (E) Western blot analysis of mGlu1 and mGlu5 receptor proteins in DS-Syn fractions isolated from human neocortical synaptosomes. The figure represents a western blot comparing the mGlu1 and mGlu5 receptor immunor- eactivities in a fraction enriched in human neocortical synaptosomal membranes. Anti-Stx-1A was used as a selective neuronal marker; 25-lg protein/lane were applied to the SDS-PAGE gel. Protein weights are in kDa. The blot in the figure is representative of 4 blots from synaptosomal preparations obtained from different patients, in different days.

Journal: Cerebral cortex (New York, N.Y. : 1991)

Article Title: The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings.

doi: 10.1093/cercor/bhp274

Figure Lengend Snippet: Figure 3. Effects of 3,5-DHPG on [3H]D-ASP and [3H]GABA-evoked exocytosis from human neocortical synaptosomes: antagonism by CPCCOEt or MPEP and western blot analysis of mGlu1/5 receptor proteins. (A) Kþ (12 mM)-evoked release of [3H]D-ASP. (B) Kþ (12 mM)-evoked release of [3H]GABA. Results are expressed as induced overflow. Time course relationship of the 12 mM Kþ-evoked release of [3H]D-ASP (C) and [3H]GABA (D) in the absence (gray circles) and in the presence (black circles) of 50 lM 3,5DHPG. Results are expressed as % of total tritium content. When not shown, error bars are within graph symbols. Data are means ± standard error of the mean of 4 (A, C) and 3 (B, D) experiments run in triplicate. *P \ 0.05 at least versus 12 mM Kþ; §P \ 0.05 at least versus 12 mM Kþ/1 lM MPEP; #P \ 0.05 at least versus respective 12 mM Kþ-evoked neurotransmitter release (expressed as % of total tritium content). (E) Western blot analysis of mGlu1 and mGlu5 receptor proteins in DS-Syn fractions isolated from human neocortical synaptosomes. The figure represents a western blot comparing the mGlu1 and mGlu5 receptor immunor- eactivities in a fraction enriched in human neocortical synaptosomal membranes. Anti-Stx-1A was used as a selective neuronal marker; 25-lg protein/lane were applied to the SDS-PAGE gel. Protein weights are in kDa. The blot in the figure is representative of 4 blots from synaptosomal preparations obtained from different patients, in different days.

Article Snippet: Veratridine, o-(carboximethyl)hydroxylamine hemihydrochloride, anti-GFAP monoclonal mouse purified immunoglobulin G (IgG) and Protease Inhibitor Cocktail were purchased from Sigma Aldrich Inc. (St Louis, MO). (RS)-3,5-d3,5-DHPG, 2-methyl-6-(phenylethynyl) pyridine hydrochloride (MPEP), and CPCCOEt were obtained from Tocris Cookson (Bristol, UK).

Techniques: Western Blot, Isolation, Marker, SDS Page

Differential changes of mGluR1- and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas CPCCOEt (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.

Journal: The Journal of Neuroscience

Article Title: Synaptic Plasticity in the Amygdala in a Model of Arthritic Pain: Differential Roles of Metabotropic Glutamate Receptors 1 and 5

doi: 10.1523/JNEUROSCI.23-01-00052.2003

Figure Lengend Snippet: Differential changes of mGluR1- and mGluR5-mediated effects in the arthritis pain model. A, In a CeA neuron recorded in a brain slice from a normal rat, MPEP (1 μm; mGluR5 antagonist) inhibited synaptic transmission, whereas CPCCOEt (10 μm; mGluR1 antagonist) had no effect.B, In a CeA neuron from an arthritic rat (6 hr after induction), both CPCCOEt and MPEP inhibited synaptic transmission, suggesting a change in the endogenous activation of mGluR1 in the arthritis pain model. Each trace is the average of 8–10 monosynaptic EPSCs recorded at –60 mV. Drugs were applied by superfusion of the slice in ACSF for at least 10 min. Data shown were recorded at 10–12 min. C, CPCCOEt inhibited synaptic transmission in neurons from arthritic rats (EC50, 94 nm;n = 9) but not in neurons from normal rats (n = 11), suggesting a change in the activation state of mGluR1 in the arthritis pain model.D, Analysis of the raw data (EPSC peak amplitude in picoamperes) shows that blocking of mGluR1 by CPCCOEt significantly reduced the increased EPSC amplitude in CeA neurons from arthritic rats to control levels measured in neurons from nonarthritic rats.E, The inhibitory effects of MPEP on synaptic transmission in CeA neurons were not significantly different in normal rats (EC50, 28.3 nm;n = 10) and in arthritis (EC50, 27.7 nm;n = 9; p> 0.05; two-way ANOVA). F, Analysis of the raw data (picoamperes) shows that MPEP reduced a larger portion of the increased EPSC in arthritis than in control neurons; however, the MPEP-insensitive component of the EPSC also increased in arthritis. ***p < 0.001; unpaired ttest.

Article Snippet: Analysis of the concentration–response relationships showed that CPCCOEt (mGluR1 antagonist) (Fig. C ) inhibited synaptic transmission at the PB→CeA synapse in the arthritis pain model (EC 50 , 94 n m ; n = 9 neurons) (Fig. C , filled circles ), whereas CPCCOEt had no significant effect on synaptic transmission under normal conditions; i.e., the slope of the concentration-response curve was not significantly different from zero ( p > 0.05; F (1,3) = 6.482; n = 11; linear regression analysis, Prism 3.0, GraphPad software) (Fig. C , open circles ).

Techniques: Slice Preparation, Transmission Assay, Activation Assay, Blocking Assay, Control

Figure 8. mGluR5 mediates group I mGluR-induced potentiation of NMDA-evoked currents. A, Current traces of NMDA-evoked currents before, during, and after application of DHPG (100 mM). The potentiation is blocked by MPEP (10 mM) but not CPCCOEt (100 mM). B, Mean data 6 SEM of percent potentiation of NMDA-evoked currents by DHPG over predrug conditions. MPEP (10 mM) significantly blocks potentiation of NMDA-evoked current compared with DHPG alone (*p , 0.05).

Journal: The Journal of Neuroscience

Article Title: Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus

doi: 10.1523/jneurosci.20-21-07871.2000

Figure Lengend Snippet: Figure 8. mGluR5 mediates group I mGluR-induced potentiation of NMDA-evoked currents. A, Current traces of NMDA-evoked currents before, during, and after application of DHPG (100 mM). The potentiation is blocked by MPEP (10 mM) but not CPCCOEt (100 mM). B, Mean data 6 SEM of percent potentiation of NMDA-evoked currents by DHPG over predrug conditions. MPEP (10 mM) significantly blocks potentiation of NMDA-evoked current compared with DHPG alone (*p , 0.05).

Article Snippet: We thank Dr. Carmelo Romano (Washington University) for supplying anti-mGluR1a and anti-mGluR5 antibodies, Dr. Darryle Schoepp and Dr. James Monn (Eli Lilly) for supplying LY354740, Dr. Rainer Kuhn (Novartis) for supplying MPEP and CPCCOEt, and Stephanie Carter for valuable technical assistance.

Techniques:

Figure 7. mGluR5 mediates group I mGluR-evoked depolarization of STN neurons. A, Membrane potential traces showing depolarization with DHPG (100 mM), which is blocked by the mGluR5-selective antagonist MPEP (10 mM). Membrane depolarization is not blocked by the mGluR1- selective antagonist CPCCOEt (100 mM). B, Mean data 6 SEM of change in membrane potential showing a significant inhibition of DHPG-mediated depolarization of STN neurons by MPEP (10 mM) compared with DHPG alone (**p , 0.001). MPEP also significantly blocks depolarization medi- ated by the mGluR5-selective agonist CBPG (100 mM) (*p , 0.05).

Journal: The Journal of Neuroscience

Article Title: Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus

doi: 10.1523/jneurosci.20-21-07871.2000

Figure Lengend Snippet: Figure 7. mGluR5 mediates group I mGluR-evoked depolarization of STN neurons. A, Membrane potential traces showing depolarization with DHPG (100 mM), which is blocked by the mGluR5-selective antagonist MPEP (10 mM). Membrane depolarization is not blocked by the mGluR1- selective antagonist CPCCOEt (100 mM). B, Mean data 6 SEM of change in membrane potential showing a significant inhibition of DHPG-mediated depolarization of STN neurons by MPEP (10 mM) compared with DHPG alone (**p , 0.001). MPEP also significantly blocks depolarization medi- ated by the mGluR5-selective agonist CBPG (100 mM) (*p , 0.05).

Article Snippet: We thank Dr. Carmelo Romano (Washington University) for supplying anti-mGluR1a and anti-mGluR5 antibodies, Dr. Darryle Schoepp and Dr. James Monn (Eli Lilly) for supplying LY354740, Dr. Rainer Kuhn (Novartis) for supplying MPEP and CPCCOEt, and Stephanie Carter for valuable technical assistance.

Techniques: Membrane, Inhibition